Assessment of Trunk Aesthetics: Development of a New Tool
TRACE2
TRACE2: Development of a New Tool for the Evaluation of the Trunk Aesthetics in Patients with Scoliosis
1 other identifier
observational
600
1 country
1
Brief Summary
Scoliosis is a three-dimensional deformity of the spine and the trunk. TRACE (Trunk Aesthetic Clinical Evaluation) is an aesthetics assessment tool for patients with scoliosis. It has been validated with Rasch analysis is easily usable in daily clinical practice. Despite this tool being more sensitive in detecting changes in aesthetics during treatment compared to other existing ones, its reliability is still low, probably due to the small number of elements that make up the rating scale. This study aims to develop a new version of the TRACE tool by adding new items. The development of TRACE2 in a Rasch environment will ensure greater sensitivity and specificity of the scale assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2023
CompletedFirst Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedOctober 3, 2024
October 1, 2024
2 years
June 12, 2023
October 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
TRACE2
New version of the TRACE tool for the assessment of trunk aesthetics in patients with scoliosis
through study completion, an average of 1 year
Study Arms (1)
Trunk Aesthetic Clinical Evaluation
Interventions
The first version of TRACE2 will be retrospectively verified through its application by experts on 150 photos of scoliosis patients who agreed to use the material produced for clinical use for retrospective research. Both intra-operator and inter-operator repeatability will be evaluated and a first Rasch analysis will be performed. The new version of TRACE2 (TRACE2.2) obtained following the retrospective validation on the photos will be verified prospectively through its application by the experts on 150 patients in specialist medical examination. Both intra-operator and inter-operator repeatability will be evaluated and further Rasch analysis will follow. On the basis of the results obtained from the analysis, the new TRACE2 scale (TRACE2.3) will then be applied to a further 150 patients, its intra- and inter-operator repeatability will be calculated and a final Rasch analysis will be performed to arrive at the final version of the scale (TRACE2.4).
Eligibility Criteria
Adolescent with a diagnosis of scoliosis
You may qualify if:
- diagnosis of scoliosis
- age between 10 and 17 years old
- scoliosis \>10° Cobb
- humps \> 5° ATR
You may not qualify if:
- History of spinal surgery
- positive neurological assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ISICO
Milan, Mi, 20141, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Negrini, MD, Phd
Istituto Scientifico Italiano Colonna Vertebrale
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2023
First Posted
June 22, 2023
Study Start
June 6, 2023
Primary Completion
June 1, 2025
Study Completion
September 1, 2025
Last Updated
October 3, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
Anonymous data will be deposited on an online repository